Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Background Perinatal depression is common, and treatment remains challenging. Depression has been reported to be associated with the abnormality of omega-3 polyunsaturated fatty acids (PUFAs). A profound decrease of omega-3 PUFAs in the mother during pregnancy is associated with the higher demand of fetal development and might precipitate the occurrence of depression. In this study, we examined the efficacy of omega-3 PUFA monotherapy for the treatment of depression during pregnancy. Method From June 2004 to June 2006, we conducted an 8-week, double-blind, placebo-controlled trial comparing omega-3 PUFAs (3.4 g/d) with placebo in pregnant women with major depressive disorder (DSM-IV criteria). No psychotropic agent was given 1 month prior to or during the study period. The Hamilton Rating Scale for Depression (HAM-D) was scored every other week as the primary measurement of efficacy, while the Edinburgh Postnatal Depression Scale (EPDS) and Beck Depression Inventory (BDI) were secondary measures. Results Thirty-six subjects were randomly assigned to either omega-3 PUFAs or placebo, and 33 among them were evaluated in more than 2 visits. A total of 24 subjects completed the study. As compared to the placebo group, subjects in the omega-3 group had significantly lower HAM-D scores at weeks 6 (p = .001) and 8 (p = .019), a significantly higher response rate (62% vs. 27%, p = .03), and a higher remission rate, although the latter did not reach statistical significance (38% vs. 18…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There were fewer very preterm births (<34 weeks’ gestation) in the DHA group compared with the control group but more post-term births requiring obstetric intervention in the DHA group compared with the control group.”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [34]
In the citing paper
“depressive symptoms, measured by the Edinburgh Postnatal Depression Scale (EPDS) at 6 weeks and 6 months postnatally did not differ between groups, nor did neurodevelopmental outcomes of their offspring differ at 18 months age [34].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [34]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Cohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,280
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
A NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162 · cited 1×
“reach a steady state because that is expected to take more than 12 weeks.(67) Finally, caution should be taken because”
BackgroundCohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
A Prospective Study of Emotional Disorders in Childbearing Women
Kumar, R., & Robson, K. M. (1984) · British Journal of Psychiatry · doi:10.1192/bjp.144.1.35 · Cited by 980
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Cited by
Identifying the women at risk of antenatal anxiety and depression: a systematic review
Biaggi, A., Conroy, S., Pawlby, S., & Pariante, C. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.014 · Cited by 1,657
“…antidepressant treatment in pregnancy (reviewed in Pariante, 2015) and have identified effective non-pharmacological treatments (Bowen et al., 2014; Su et al., 2008; Thomas et al., 2014), although more research is still need to be done regarding the effectiveness of non-pharmacological…”
BackgroundSelf-citationOmega-3 fatty acids EPA and DHA: Health benefits throughout life
Swanson, D., Block, R., & Mousa, S. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.000893 · Cited by 1,575
“Introduction Omega-3 [(n-3)] long-chain PUFA, including EPA and DHA, are dietary fats with an array of health benefits (1).”
BackgroundPRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Self-citationKennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
“Subsequent studies have been published, with mixed results (Freeman et al., 2008; Jazayerim et al., 2008; Mischoulon et al., 2008; Rogers et al., 2008; Su et al., 2008).”
ResultOmega-3 fatty acid addition during pregnancy
Middleton, P., Gomersall, J. C., Gould, J. F., Shepherd, E., Olsen, S. F., & Makrides, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003402.pub3 · Cited by 442
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
“studies conducted on pregnant women with MDD [82,93,99] (Figure 6) and those on apparently healthy women (primary prevention) [51,68,85] (Figure 7).”
BackgroundMeta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
Sublette, M. E., Ellis, S. P., Geant, A. L., & Mann, J. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06634 · Cited by 417
“39 Two studies involved participants with a major depressive episode in association with a medical illness: Parkinson’s disease 18 and coronary heart disease.”
Diet, Stress and Mental Health
Bremner, J., Moazzami, K., Wittbrodt, M., Nye, J., Lima, B., Gillespie, C., Rapaport, M., Pearce, B., Shah, A., & Vaccarino, V. (2020) · Nutrients · doi:10.3390/nu12082428 · Cited by 377
Martins, J. G. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719785 · Cited by 358
“[39,40] studies in the current meta-analysis has resulted in overestimation of v3 LCPUFA supplementation treatment effects.”
BackgroundMethodResultInfluentialAppleton, K. M., Rogers, P. J., & Ness, A. R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28313 · Cited by 353
Perinatal Depression: Prevalence, Risks, and the Nutrition Link—A Review of the Literature
Leung, B. M. Y., & Kaplan, B. J. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.06.368 · Cited by 306
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Borsini, A., Nicolaou, A., Camacho-Muñoz, D., Kendall, A. C., Di Benedetto, M. G., Giacobbe, J., Su, K.-P., & Pariante, C. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01160-8 · Cited by 234
Self-citationChang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.160 · Cited by 248
Self-citationBai, S., Guo, W., Feng, Y., Deng, H., Li, G., Nie, H., Guo, G., Yu, H., Ma, Y., Wang, J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320912 · Cited by 235
Antioxidants as potential therapeutics for neuropsychiatric disorders
Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222
“…and CGI Q8Nemets et al. (2006) ontrolled No significant effect on symptom scores Freeman et al. (2008) controlled Significantly lower HAMD scores Su et al., 2008 peutics for neuropsychiatric disorders, Prog Neuro-Psychopharmacol T 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371…”
Nillni, Y. I., Mehralizade, A., Mayer, L., & Milanovic, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.004 · Cited by 207
Guu, T.-W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., Freeman, M. P., Maes, M., Matsuoka, Y. J., Belmaker, R. H., et al. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000502652 · Cited by 191
Self-citationSu, K.-P., Lai, H.-C., Yang, H.-T., Su, W.-P., Peng, C.-Y., Chang, J. P.-C., Chang, H.-C., & Pariante, C. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.008 · Cited by 205
Self-citationEfficacy of omega-3 highly unsaturated fatty acids in the treatment of depression
Hallahan, B., Ryan, T., Hibbeln, J. R., Murray, I. T., Glynn, S., Ramsden, C. E., SanGiovanni, J. P., & Davis, J. M. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.160242 · Cited by 188
Song, C., Shieh, C.-H., Wu, Y.-S., Kalueff, A., Gaikwad, S., & Su, K.-P. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.003 · Cited by 187
Self-citationSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data
Bozzatello, P., Brignolo, E., De Grandi, E., & Bellino, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5080067 · Cited by 179
“An interesting study on 36 pregnant women with major depressive disorder [42] compared omega-3 HUFAs monotherapy (2.”
Treatment of post-partum depression: a review of clinical, psychological and pharmacological options
Leight, K., Fitelson, Kim, S., & Baker, A. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s6938 · Cited by 163
Omega-3 fatty acids for depression in adults
Appleton, K. M., Sallis, H. M., Perry, R., Ness, A. R., & Churchill, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004692.pub4 · Cited by 180
Lu, D.-Y., Tsao, Y.-Y., Leung, Y.-M., & Su, K.-P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.98 · Cited by 179
“(Freeman et al, 2006; Lin and Su, 2007; Su et al, 2008).”
Self-citationOmega 3 fatty acids, gestation and pregnancy outcomes
Larqué, E., Gil-Sánchez, A., Prieto-Sánchez, M. T., & Koletzko, B. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001481 · Cited by 182
“Only Su et al.((68)) with 36 depressed subjects receiving 1·2 g DHA þ 2·2 g EPA found reduced depression scores, although no placebo group was included in this study.”
Du, J., Zhu, M., Bao, H., Li, B., Dong, Y., Xiao, C., Zhang, G. Y., Henter, I., Rudorfer, M., & Vitiello, B. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876960 · Cited by 162
“Indeed, most of the clinical trials using predominantly 1–2g EPA/day exhibited significant beneficial effects in depression patients (Hallahan et al., 2007, Jazayeri et al., 2008, Mischoulon et al., 2009, Nemets et al., 2002, Peet and Horrobin, 2002, Su et al., 2003, Su et al., 2008a).”
BackgroundSu, K.-P. (2009) · Neurosignals · doi:10.1159/000198167 · Cited by 168
Self-citationSu, K.-P., Huang, S.-Y., Peng, C.-Y., Lai, H.-C., Huang, C.-L., Chen, Y.-C., Aitchison, K. J., & Pariante, C. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.005 · Cited by 165
Self-citationKoletzko, B., Boey, C. C. M., Campoy, C., Carlson, S. E., Chang, N., Guillermo-Tuazon, M. A., Joshi, S., Prell, C., Quak, S. H., Sjarif, D. R., et al. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000365767 · Cited by 156
Mood disorders and complementary and alternative medicine: a literature review
Qureshi, N. A., & Al-Bedah (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s43419 · Cited by 155
Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
Self-citationImhoff‐Kunsch, B., Briggs, V. G., Goldenberg, T., & Ramakrishnan, U. (2012) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2012.01292.x · Cited by 153
DiNicolantonio, J. J., & O’Keefe, J. H. (2020) · Nutrients · doi:10.3390/nu12082333 · Cited by 147
Martins, J. G., Bentsen, H., & Puri, B. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.25 · Cited by 150
Zhang, Z., Fulgoni, V. L. I., Kris‐Etherton, P. M., & Mitmesser, S. H. (2018) · Nutrients · doi:10.3390/nu10040416 · Cited by 158
“For instance, 800 mg per day DHA supplementation during pregnancy did not significantly ameliorate postpartum depressive symptoms measured by the Edinburgh Postnatal Depression Scale [46]; whereas 3400 mg per day EPA and DHA supplementation for eight weeks during pregnancy favorably improved depression measured by the…”
MethodOmega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders
Su, K.-P., Matsuoka, Y., & Pae, C.-U. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.2.129 · Cited by 134
Self-citationVan Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
“Several lines of evidence have suggested the efficacy of n-3 LCPUFA as a MDD risk reduction or dietary management strategy in epidemiological and case-controlled studies [98,99], randomized-controlled trials [100-110], and meta-analyses [111-120].”
BackgroundNutritional Factors Affecting Mental Health
Lim, S. Y., Kim, E. J., Kim, A., Lee, H. J., Choi, H. J., & Yang, S. J. (2016) · Clinical Nutrition Research · doi:10.7762/cnr.2016.5.3.143 · Cited by 147
“83 g DHA) Ameliorate depressive symptoms and improve quality of life [35] 36 pregnant/depressive women, omega-3 FAs (n = 18) and placebo (n = 18) for 8 wk 3.”
BackgroundHigh Levels of Depressive Symptoms in Pregnancy With Low Omega-3 Fatty Acid Intake From Fish
Golding, J., Steer, C., Emmett, P., Davis, J. M., & Hibbeln, J. R. (2009) · Epidemiology · doi:10.1097/ede.0b013e31819d6a57 · Cited by 131
Omega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
Khan, I. R., Hussain, M., Jiang, B., Zheng, L., Pan, Y., Hu, J., Khan, A., Ashraf, A., & Zou, X. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101255 · Cited by 138
Complementary and alternative medicine therapies for perinatal depression
Deligiannidis, K. M., & Freeman, M. P. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.08.007 · Cited by 124
The Role of Essential Fatty Acids in Human Health
Glick, N. R., & Fischer, M. H. (2013) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587213488788 · Cited by 133
“2 g were given.(142,143) First-trimester dietary n-6/n-3 ratios greater than 9:1 have been associated with more than twice the risk of subsequent postpartum depression.”
BackgroundLow Omega-3 Index in Pregnancy Is a Possible Biological Risk Factor for Postpartum Depression
Markhus, M. W., Skotheim, S., Graff, I. E., Frøyland, L., Braarud, H. C., Stormark, K. M., & Malde, M. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067617 · Cited by 116
Background Paper on Fat and Fatty Acid Requirements during Pregnancy and Lactation
Brenna, J. T., & Lapillonne, A. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000228998 · Cited by 116
“Su et al., 2008 24 Menhaden oil 1.2 g DHA 2.2 g EPA mid-gestation, duration 8 weeks Depressive symptoms reduced; higher response rate to treatment.”
BackgroundResultInfluentialSinn, N., Milte, C., & Howe, P. R. C. (2010) · Nutrients · doi:10.3390/nu2020128 · Cited by 115
“…olive oil placebo 4 month parallel design, adjunctive therapy HDRS, BDI, GAFS Treatment = placebo on outcome measures (improvements in both groups) Su et al. (2008) [109] N = 24 (18-40 years); with major depressive disorder during pregnancy 2.2g EPA + 1.2g DHA or placebo, both with tocopherols &…”
MethodPerinatal depression: treatment options and dilemmas
Pearlstein, T. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0829 · Cited by 107
“A recent small study reported that omega-3 fatty acids were superior to placebo for depression during pregnancy.(142) Although not specifically studied in pregnant women with depression, moderate exercise is noted to improve maternal well-being without adverse effects on birth outcomes.”
Intergenerational transmission of depression: clinical observations and molecular mechanisms
Sawyer, K. M., Zunszain, P. A., Dazzan, P., & Pariante, C. M. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0265-4 · Cited by 115
“In our trial using this approach in women with a diagnosis of major depressive disorder in pregnancy, we found that omega-3 supplementation reduces depressive symptoms [217].”
MethodSelf-citationRavindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial
Mozurkewich, E. L., Clinton, C. M., Chilimigras, J. L., Hamilton, S. E., Allbaugh, L. J., Berman, D. R., Marcus, S. M., Romero, V. C., Treadwell, M. C., Keeton, K. L., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.038 · Cited by 109
Smith, C. A., Shewamene, Z., Galbally, M., Schmied, V., & Dahlen, H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.054 · Cited by 98
Labrousse, V. F., Leyrolle, Q., Amadieu, C., Aubert, A., Sere, A., Coutureau, E., Grégoire, S., Bretillon, L., Pallet, V., Gressens, P., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.004 · Cited by 94
Doornbos, B., van Goor, S. A., Dijck-Brouwer, D. A. J., Schaafsma, A., Korf, J., & Muskiet, F. A. J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.003 · Cited by 100
The Interplay between Maternal Nutrition and Stress during Pregnancy: Issues and Considerations
Lindsay, K. L., Buss, C., Wadhwa, P. D., & Entringer, S. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000457136 · Cited by 93
Antonietta Ajmone‐Cat, M., Lavinia Salvatori, M., De Simone, R., Mancini, M., Biagioni, S., Bernardo, A., Cacci, E., & Minghetti, L. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22783 · Cited by 97
“…their neuroprotective effects in the ageing brain, after brain hypoxia and ischemia (Kalmijn et al., 1997; Gamoh et al., 2001; Morris et al., 2005; Dyall et al., 2007; Bazan, 2009; Niemoller and Bazan, 2010), and in the treatment of major depression and other affective disorders (Su et al., 2008).”
BackgroundOmega-3 fatty acids and the treatment of depression: a review of scientific evidence
Wani, A. L., Bhat, S. A., & Ara, A. (2015) · Integrative Medicine Research · doi:10.1016/j.imr.2015.07.003 · Cited by 97
A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
Mischoulon, D., Papakostas, G. I., Dording, C. M., Farabaugh, A. H., Sonawalla, S. B., Agoston, A. M., Smith, J., Beaumont, E. C., Dahan, L. E., Alpert, J. E., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04603 · Cited by 94
Usuda, K., Nishi, D., Okazaki, E., Makino, M., & Sano, Y. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12562 · Cited by 98
Major Depressive Disorder Is Associated With Cardiovascular Risk Factors and Low Omega-3 Index
Baghai, T. C., Varallo-Bedarida, G., Born, C., Häfner, S., Schüle, C., Eser, D., Rupprecht, R., Bondy, B., & von Schacky, C. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05895blu · Cited by 93
Miyake, Y., Tanaka, K., Okubo, H., Sasaki, S., & Arakawa, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.012 · Cited by 91
“2 g of DHA, significantly improved depressive symptoms in pregnant women with major depressive disorder (Su et al., 2008).”
BackgroundPolyunsaturated Fatty Acids in Perinatal Depression: A Systematic Review and Meta-analysis
Lin, P., Chang, C., Chong, M. F., Chen, H., & Su, K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1182 · Cited by 94
Self-citationHsu, M., Tung, C.-Y., & Chen, H.-E. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.018 · Cited by 93
“833, respectively) for approximately 8 weeks improved the depression scores (Freeman et al., 2006a; Su et al., 2008).”
BackgroundMethodDennis, C.-L., & Dowswell, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006795.pub3 · Cited by 83
Sarris, J., Schoendorfer, N., & Kavanagh, D. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00180.x · Cited by 85
Omega-3 fatty acids for depression in adults
Appleton, K. M., Voyias, P. D., Sallis, H. M., Dawson, S., Ness, A. R., Churchill, R., & Perry, R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004692.pub5 · Cited by 84
Cattane, N., Räikkönen, K., Anniverno, R., Mencacci, C., Riva, M. A., Pariante, C. M., & Cattaneo, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0813-6 · Cited by 95
Self-citationNutrition and the psychoneuroimmunology of postpartum depression
Ellsworth-Bowers, E. R., & Corwin, E. J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000091 · Cited by 86
“Of the eight studies, six report no effect of n-3 PUFA supplementation on perinatal depression, while two studies report an inverse association between n-3 PUFA supplementation and perinatal depression((51,52)).”
BackgroundInflammation in psychopathology of depression: Clinical, biological, and therapeutic implications
Su, K. (2012) · Biomedicine · doi:10.1016/j.biomed.2012.03.002 · Cited by 80
“[73] Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, et al.”
BackgroundSelf-citationDennis, C.-L., & Allen, K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006795.pub2 · Cited by 69
Chang, J. P., & Su, K. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.469 · Cited by 82
“prove and prevent symptoms of depression [5,6,10,11], ADHD [7,12] and ASD [13], and cognitive function in mild cognitive impairment [8] in clinical trials.”
BackgroundResultInfluentialSelf-citationDepression, Suicide and Deficiencies of Omega–3 Essential Fatty Acids in Modern Diets
Hibbeln, J. R. (2008) · World Review of Nutrition and Dietetics · doi:10.1159/000192992 · Cited by 72
Strøm, M., Mortensen, E. L., Halldorsson, T. I., Thorsdottir, I., & Olsen, S. F. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27552 · Cited by 74
Liu, J. J., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07970 · Cited by 73
Emerging targets for antidepressant therapies
Rakofsky, J. J., Holtzheimer, P. E., & Nemeroff, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.617 · Cited by 72
“Omega-3 fatty acids may be useful in patients with perinatal depression as well [111], though results are mixed [112].”
Dietary supplements for preventing postnatal depression
Miller, B. J., Murray, L., Beckmann, M. M., Kent, T., & Macfarlane, B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009104.pub2 · Cited by 63
Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression
Bae, J.-H., & Kim, G. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.10.013 · Cited by 78
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology
Pusceddu, M. M., Kelly, P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw078 · Cited by 70
Zhang, M.-M., Zou, Y., Li, S., Wang, L., Sun, Y.-H., Shi, L., Lü, L., Bao, Y., & Li, S. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00886-3 · Cited by 76
Pharmacokinetics of Sertraline Across Pregnancy and Postpartum
Freeman, M. P., Nolan, P. E., Davis, M. F., Anthony, M., Fried, K., Fankhauser, M., Woosley, R. L., & Moreno, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818d2048 · Cited by 66
McNamara, R. K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.017 · Cited by 74
“patients with MDD [84,88,94], whereas a smaller EPA:DHA ratio is not associated with significant advantage over placebo”
BackgroundInfluentialRole of docosahexaenoic acid in maternal and child mental health
Ramakrishnan, U., Imhoff‐Kunsch, B., & DiGirolamo, A. M. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26692f · Cited by 66
Clarke, G., Fitzgerald, P., Hennessy, A. A., Cassidy, E. M., Quigley, E. M. M., Ross, P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p000695 · Cited by 62
Luo, X., Feng, J., Yang, Z., Huang, Q., Lin, J., Yang, B., Su, K., & Pan, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02656-3 · Cited by 68
“Additionally, by considering that pregnant women can be administrated in a high dose [36], we tentatively infer the safety of n-3 PUFAs is acceptable in the short term.”
BackgroundSelf-citationn-3 LC-PUFA supplementation: effects on infant and maternal outcomes
Giuseppe, R. D., Roggi, C., & Cena, H. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0660-9 · Cited by 69
“2 g DHA) on perinatal depression in Taiwanese women [37]; therefore, Jans et al.”
Simon, M. S., Arteaga-Henríquez, G., Algendy, A. F., Siepmann, T., & Illigens, B. M. W. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s385117 · Cited by 65
“Nevertheless, response to anti-inflammatory agents like minocycline, celecoxib, or omega 3 fatty acids and their superiority over the placebo condition has been shown (eg, Husain et al, Su et al).(23,35,36) Noteworthy, some studies show contradictory results in that no significant difference was found between the trea…”
ResultYang, C., Chang, C., Yang, C., Pariante, C. M., & Su, K. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.001 · Cited by 62
Self-citationComplementary and alternative medicine for perinatal depression
Freeman, M. P. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.017 · Cited by 62
“demonstrated a significant benefit of omega-3 fatty acids compared with placebo in antenatal depression (Su et al., 2008).”
BackgroundLi, Y., Dai, Q., Ekperi, L., Dehal, A. N., & Zhang, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.05.012 · Cited by 58
“, 2009), as well as randomized trials (Peet and Horrobin, 2002; Nemets et al., 2006; Su et al., 2008; Lesperance et al., 2010; Rondanelli et al., 2010), indicating that diets containing Ω-3 fatty acids, particularly fish and other seafood, may prevent depression and play a role in the prevention and treatment of menta…”
InfluentialThe efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression
Jans, L. A. W., Giltay, E. J., & Willem Van der Does, A. J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510004125 · Cited by 53
“The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression Linda A. W. Jans1*, Erik J. Giltay2 and A. J. Willem Van der Does1,2 1Institute of Psychology, Leiden University, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands 2Department of Psychiatry, Leiden University Medical Center, Leiden, The N…”
BackgroundMethodResultInfluentialBorsini, A., Stangl, D., Jeffries, A. R., Pariante, C. M., & Thuret, S. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00908-0 · Cited by 55
Self-citationRole of long-chain omega-3 fatty acids in psychiatric practice
McNamara, R. K., & Strawn, J. R. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2012.10.004 · Cited by 48
Milte, C. M., Sinn, N., & Howe, P. R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00229.x · Cited by 50
La dépression de l’antepartum : prévalence, diagnostic, traitement
Chatillon, O., & EVEN, C. (2010) · L Encéphale · doi:10.1016/j.encep.2010.02.004 · Cited by 61
Kim, S. H., Sunwoo, I. Y., Hong, H. J., Awah, C. C., Jeong, G.-T., & Kim, S.-K. (2019) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-019-02149-y · Cited by 50
Perinatal depression and omega-3 fatty acids: A Mendelian randomisation study
Sallis, H., Steer, C. D., Paternoster, L., Smith, G. D., & Evans, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.077 · Cited by 56
“Due to the increased nutritional demands on the body and the suspected resultant decrease in levels of highly unsaturated brain FAs during the antenatal and postnatal periods, women may be especially at risk of developing depressive symptoms at this time (Su et al., 2008; Kendall-Tackett, 2010).”
BackgroundInfluentialVaz, J. D. S., Farias, D. R., Adegboye, A. R. A., Nardi, A. E., & Kac, G. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1365-x · Cited by 54
Yang, B., Lin, L., Bazinet, R. P., Chien, Y.-C., Chang, J. P., Satyanarayanan, S. K., Su, H., & Su, K. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501158 · Cited by 53
Self-citationOmega-3 polyunsaturated fatty acids for major depressive disorder
Su, K.-P., Wang, S.-M., & Pae, C.-U. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.836487 · Cited by 47
“In addition, the clinical studies from double-blind randomized clinical trials and systemic meta-analyses have shown the potential application to use omega-3 fatty acids in the treatment of clinical depression [17,25,26], especially for special populations of children [27] or pregnant women [28] with MDD.”
BackgroundMethodResultInfluentialSelf-citationImhoff‐Kunsch, B., Stein, A. D., Villalpando, S., Martorell, R., & Ramakrishnan, U. (2010) · Journal of Nutrition · doi:10.3945/jn.110.126870 · Cited by 57
Metadata
- Authors
- Su, K.-P., Huang, S.-Y., Chiu, T.-H., Huang, K.-C., Huang, C.-L., Chang, H.-C., & Pariante, C. M.
- Affiliations
- King's College London (GB)
- Taipei Medical University (TW)
- China Medical University (TW)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-04-15
- Volume
- 69
- Issue
- 4
- Pages
- 644-651
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2022352764
- Cited by
- 308
- References
- 67
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 15 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 28 · 2019: 14 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 20 · 2014: 16 · 2013: 24 · 2012: 16
- FWCI
- 25.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- omega-3 fatty acids, polyunsaturated fatty acids, major depressive disorder, perinatal depression, antenatal depression, antidepressant monotherapy, maternal depression, fetal development, treatment response and remission, drug safety in pregnancy
- MeSH terms
- Adult, Chromatography, Gas, Major Depressive Disorder, Double-Blind Method, Female, Humans, Pregnancy, Pregnancy Complications, Surveys and Questionnaires, Fatty Acids, Omega-3, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.